Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy
This study aimed to evaluate long-term changes in patients treated with combined modality.
DESIGN:
This was a retrospective study of prospectively collected patient-reported outcome surveys.
SETTING:
This study was conducted at a single institution.
PATIENTS:
There were 143 patients with stage I to III anal cancer who were treated with chemoradiation and had completed the survey.
MAIN OUTCOME MEASURES:
This study included patient-reported outcomes reflecting bowel, sexual, and urinary function.
RESULTS:
Thirty-nine percent of patients had major low anterior resection syndrome at baseline. Major low anterior resection syndrome remained stable (38%; 95% CI, 31%–46%) with no change over time (OR 0.95; 95% CI, 0.74–1.21; p = 0.7). Higher rates of major low anterior resection syndrome were observed for patients who had major low anterior resection syndrome at baseline (OR 20.7; 95% CI 4.70–91.3; p
Source: Diseases of the Colon and Rectum - Category: Gastroenterology Tags: Original Contributions: Anal Neoplasia Source Type: research
More News: Anal Cancer | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Gastroenterology | Squamous Cell Carcinoma | Study